Condition: Cerebrovascular Disorders · Sponsor: Assistance Publique - Hôpitaux de Paris
The purpose of the study is to test the hypothesis of slowing the progression of White Matter Lesions (WML) by lowering blood pressure (BP) in patients with cognitive complaints and a moderate to high grade of WML on brain MRI.
This description comes directly from the study's public registry record.
Olivier HANON, MD, PhD · 33 1 44 08 35 02 · olivier.hanon@brc.aphp.fr
Christophe TZOURIO, MD, PhD · christophe.tzourio@u-bordeaux.fr
Always discuss trial participation with your own doctor first.
| Memory for Research and Resources Center / Neuroscience pole | Bordeaux, Pellegrin Hospital Group, France | Not Yet Recruiting |
| Memory Resources Centre and South of Ile de France Search - Broca Hospital | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02472028